Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8547 |
High Similarity |
NPD8434 |
Phase 2 |
0.8457 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.8457 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.8253 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7943 |
Intermediate Similarity |
NPD6765 |
Approved |
0.7943 |
Intermediate Similarity |
NPD6764 |
Approved |
0.7765 |
Intermediate Similarity |
NPD6785 |
Approved |
0.7765 |
Intermediate Similarity |
NPD6784 |
Approved |
0.7692 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7661 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7515 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7459 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7427 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7341 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7337 |
Intermediate Similarity |
NPD8404 |
Phase 2 |
0.733 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7317 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7283 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7262 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7251 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7241 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7216 |
Intermediate Similarity |
NPD919 |
Approved |
0.7191 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7182 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7182 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7159 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7151 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD920 |
Approved |
0.7135 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7127 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.712 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7118 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.711 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7108 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7101 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7081 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7081 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7077 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7072 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7062 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7043 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7033 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7018 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7017 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7017 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7017 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7017 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.6994 |
Remote Similarity |
NPD7239 |
Suspended |
0.6989 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6977 |
Remote Similarity |
NPD6273 |
Approved |
0.6973 |
Remote Similarity |
NPD8368 |
Discontinued |
0.6973 |
Remote Similarity |
NPD7251 |
Discontinued |
0.694 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6935 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6932 |
Remote Similarity |
NPD1934 |
Approved |
0.6919 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD2533 |
Approved |
0.6919 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD2532 |
Approved |
0.6919 |
Remote Similarity |
NPD2534 |
Approved |
0.6909 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6906 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6901 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6882 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6872 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6868 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6866 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6866 |
Remote Similarity |
NPD7874 |
Approved |
0.6865 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6864 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6857 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6857 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6851 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6848 |
Remote Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD2796 |
Approved |
0.6845 |
Remote Similarity |
NPD6100 |
Approved |
0.6845 |
Remote Similarity |
NPD6099 |
Approved |
0.6837 |
Remote Similarity |
NPD6781 |
Approved |
0.6837 |
Remote Similarity |
NPD6778 |
Approved |
0.6837 |
Remote Similarity |
NPD6782 |
Approved |
0.6837 |
Remote Similarity |
NPD6777 |
Approved |
0.6837 |
Remote Similarity |
NPD6776 |
Approved |
0.6837 |
Remote Similarity |
NPD6780 |
Approved |
0.6837 |
Remote Similarity |
NPD6779 |
Approved |
0.6836 |
Remote Similarity |
NPD37 |
Approved |
0.6818 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6818 |
Remote Similarity |
NPD7698 |
Approved |
0.6818 |
Remote Similarity |
NPD7697 |
Approved |
0.6816 |
Remote Similarity |
NPD4966 |
Approved |
0.6816 |
Remote Similarity |
NPD4965 |
Approved |
0.6816 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6811 |
Remote Similarity |
NPD7054 |
Approved |
0.6805 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6805 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6805 |
Remote Similarity |
NPD5763 |
Approved |
0.6805 |
Remote Similarity |
NPD5762 |
Approved |
0.6798 |
Remote Similarity |
NPD2801 |
Approved |
0.6786 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6784 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6784 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6779 |
Remote Similarity |
NPD7907 |
Approved |
0.6776 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6774 |
Remote Similarity |
NPD7472 |
Approved |
0.6763 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.6746 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6746 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6744 |
Remote Similarity |
NPD6190 |
Approved |
0.6727 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6727 |
Remote Similarity |
NPD3268 |
Approved |
0.6725 |
Remote Similarity |
NPD2800 |
Approved |
0.6725 |
Remote Similarity |
NPD1243 |
Approved |
0.6724 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6722 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6719 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6719 |
Remote Similarity |
NPD8435 |
Approved |
0.6714 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6706 |
Remote Similarity |
NPD2344 |
Approved |
0.67 |
Remote Similarity |
NPD8319 |
Approved |
0.67 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6687 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6686 |
Remote Similarity |
NPD3750 |
Approved |
0.6683 |
Remote Similarity |
NPD4665 |
Approved |
0.6683 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD7095 |
Approved |
0.6667 |
Remote Similarity |
NPD4107 |
Approved |
0.6667 |
Remote Similarity |
NPD7801 |
Approved |
0.6667 |
Remote Similarity |
NPD7228 |
Approved |
0.6667 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6649 |
Remote Similarity |
NPD2403 |
Approved |
0.6648 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6648 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6647 |
Remote Similarity |
NPD3887 |
Approved |
0.6632 |
Remote Similarity |
NPD8360 |
Approved |
0.6632 |
Remote Similarity |
NPD8361 |
Approved |
0.663 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.663 |
Remote Similarity |
NPD7058 |
Phase 2 |
0.663 |
Remote Similarity |
NPD7057 |
Phase 3 |
0.663 |
Remote Similarity |
NPD6808 |
Phase 2 |
0.6627 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6627 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6627 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6615 |
Remote Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.6611 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6611 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.66 |
Remote Similarity |
NPD3057 |
Approved |
0.6599 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6591 |
Remote Similarity |
NPD1512 |
Approved |
0.6591 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6588 |
Remote Similarity |
NPD3748 |
Approved |
0.6588 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6585 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6585 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6582 |
Remote Similarity |
NPD6534 |
Approved |
0.6582 |
Remote Similarity |
NPD6535 |
Approved |
0.6567 |
Remote Similarity |
NPD7497 |
Discontinued |
0.6566 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6566 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6552 |
Remote Similarity |
NPD2354 |
Approved |
0.6552 |
Remote Similarity |
NPD2309 |
Approved |
0.655 |
Remote Similarity |
NPD4482 |
Phase 3 |
0.6543 |
Remote Similarity |
NPD1608 |
Approved |
0.6543 |
Remote Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.6541 |
Remote Similarity |
NPD5711 |
Approved |
0.6541 |
Remote Similarity |
NPD5710 |
Approved |
0.654 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.6527 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6527 |
Remote Similarity |
NPD3764 |
Approved |
0.6526 |
Remote Similarity |
NPD7240 |
Approved |
0.6524 |
Remote Similarity |
NPD3266 |
Approved |
0.6524 |
Remote Similarity |
NPD1049 |
Clinical (unspecified phase) |
0.6524 |
Remote Similarity |
NPD3267 |
Approved |
0.6517 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6517 |
Remote Similarity |
NPD3533 |
Approved |
0.6517 |
Remote Similarity |
NPD2972 |
Approved |
0.6515 |
Remote Similarity |
NPD8485 |
Approved |
0.6512 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6512 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6512 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6512 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6512 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6509 |
Remote Similarity |
NPD447 |
Suspended |
0.65
|
Remote Similarity |
NPD4580 |
Approved |